Big Pharmas Such as Roche (RHHBY). Eli Lilly and Company (LLY) Crunch the Numbers to Boost Odds Against Cancer
11/2/2012 7:48:42 AM
Software engineers are moving to the fore in the war on cancer, designing programmes that sift genetic sequencing data at lightning speed and minimal cost to identify patterns in tumors that could lead to the next medical breakthrough.
Their analysis aims to pinpoint the mutations in our genetic code that drive cancers as diverse as breast, ovarian and bowel. The more precise their work is, the better the chance of developing an effective new drug.